UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor regulation of the tissue environment in the liver

Pharmacology & therapeutics (Oxford), 2017-05, Vol.173, p.47-57

2017

Volltextzugriff (PDF)

Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

Cancer cell, 2016-10, Vol.30 (4), p.533-547

2016

Volltextzugriff (PDF)

Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow

Immunity (Cambridge, Mass.), 2020-08, Vol.53 (2), p.319-334.e6

2020

Volltextzugriff (PDF)

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma

Digestion, 2017-01, Vol.96 (1), p.1-4

2017

Volltextzugriff (PDF)

Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases

The Journal of immunology (1950), 2020-01, Vol.204 (1), p.192-198

2020

Volltextzugriff (PDF)

CyTOF mass cytometry reveals phenotypically distinct human blood neutrophil populations differentially correlated with melanoma stage

Journal for immunotherapy of cancer, 2020-09, Vol.8 (2), p.e000473

2020

Volltextzugriff (PDF)

Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy

Frontiers in immunology, 2023-10, Vol.14, p.1261070-1261070

2023

Volltextzugriff (PDF)

Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage

PloS one, 2014-11, Vol.9 (11), p.e112717-e112717

2014

Volltextzugriff (PDF)

Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database

United European gastroenterology journal, 2013-10, Vol.1 (5), p.351-357

2013

Volltextzugriff (PDF)

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage

Cancer immunology research, 2015-05, Vol.3 (5), p.557-566

2015

Volltextzugriff (PDF)

The Potential of Nano-Porous Surface Structure for Pain Therapeutic Applications: Surface Properties and Evaluation of Pain Perception

Applied sciences, 2020-07, Vol.10 (13), p.4578

2020

Volltextzugriff (PDF)

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis

Nature (London), 2016-03, Vol.531 (7593), p.253-257

2016

Volltextzugriff (PDF)

Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer

Hepatology (Baltimore, Md.), 2021-04, Vol.73 (4), p.1399-1418

2021

Volltextzugriff (PDF)

Hepatic myeloid-derived suppressor cells in cancer

Cancer Immunology, Immunotherapy, 2015-08, Vol.64 (8), p.931-940

2015

Volltextzugriff (PDF)

Identification of a CD117+CD71+ early neutrophil progenitor population in human bone marrow

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.63-63.6

2020

Volltextzugriff (PDF)

Patrolling monocytes control NK cell expression of activating and stimulatory receptors to curtail lung metastases2

The Journal of immunology (1950), 2019-11, Vol.204 (1), p.192-198

2019

Volltextzugriff (PDF)

Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10

Gut, 2013-11, Vol.62 (11), p.1667-1668

2013

Volltextzugriff (PDF)

Vacuum-sealed field emission electron gun

Journal of vacuum science and technology. B, Nanotechnology & microelectronics, 2020-03, Vol.38 (2)

2020

Volltextzugriff (PDF)

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2024-04, Vol.30 (8), p.1488-1500

2024

Volltextzugriff (PDF)

Safety and efficacy of AMG 160, a half-life extended BiTE immune therapy targeting prostate-specific membrane antigen (PSMA), and other therapies for metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS5088-TPS5088

2021

Volltextzugriff (PDF)

Cellular senescence associated immune responses in liver cancer

Hepatic oncology, 2017-10, Vol.4 (4), p.123-127

2017

Volltextzugriff (PDF)

Abstract 360: Senescent hepatocytes secrete CCL2 to accelerate liver cancer growth via accumulation of immunosuppressive myeloid cells

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.360-360

2015

Volltextzugriff (PDF)

Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?

Gut, 2014-09, Vol.63 (9), p.1524-1524

2014

Volltextzugriff (PDF)

Abstract A04: Systemic agonistic anti-CD40 treatment of tumor bearing mice modulates hepatic myeloid suppressive cells and causes immune-mediated liver damage

Cancer immunology research, 2015-10, Vol.3 (10_Supplement), p.A04-A04

2015

Volltextzugriff (PDF)

Epidemiology of fibrolamellar hepatocellular carcinoma in the U.S., 2000–2010

Gut, 2013-05, Vol.62 (11), p.1667-1668

2013

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(110)
Deutsch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor regulation of the tissue environment in the liver

Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma

Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases

CyTOF mass cytometry reveals phenotypically distinct human blood neutrophil populations differentially correlated with melanoma stage

Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy

Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage

Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage

The Potential of Nano-Porous Surface Structure for Pain Therapeutic Applications: Surface Properties and Evaluation of Pain Perception

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis

Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer

Hepatic myeloid-derived suppressor cells in cancer

Identification of a CD117+CD71+ early neutrophil progenitor population in human bone marrow

Patrolling monocytes control NK cell expression of activating and stimulatory receptors to curtail lung metastases2

Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10

Vacuum-sealed field emission electron gun

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

Safety and efficacy of AMG 160, a half-life extended BiTE immune therapy targeting prostate-specific membrane antigen (PSMA), and other therapies for metastatic castration-resistant prostate cancer (mCRPC)

Cellular senescence associated immune responses in liver cancer

Abstract 360: Senescent hepatocytes secrete CCL2 to accelerate liver cancer growth via accumulation of immunosuppressive myeloid cells

Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?

Abstract A04: Systemic agonistic anti-CD40 treatment of tumor bearing mice modulates hepatic myeloid suppressive cells and causes immune-mediated liver damage

Epidemiology of fibrolamellar hepatocellular carcinoma in the U.S., 2000–2010

Suchergebnisse filtern